Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid …
Over the last 12 months, insiders at Merit Medical Systems, Inc. have bought $0 and sold $12.32M worth of Merit Medical Systems, Inc. stock.
On average, over the past 5 years, insiders at Merit Medical Systems, Inc. have bought $49,967 and sold $7.52M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,159 shares for transaction amount of $49,967 was made by Floyd David (director) on 2020‑08‑04.
2024-11-15 | Sale | director | 12,500 0.0215% | $101.55 | $1.27M | +2.21% | ||
2024-11-07 | Sale | CFO AND TREASURER | 5,361 0.0092% | $102.18 | $547,787 | +1.41% | ||
2024-11-05 | Sale | CFO AND TREASURER | 29,646 0.0504% | $98.02 | $2.91M | -0.25% | ||
2024-11-05 | Sale | CHIEF OPERATING OFFICER | 5,000 0.0085% | $98.00 | $490,000 | -0.25% | ||
2024-06-28 | Sale | director | 12,500 0.022% | $85.00 | $1.06M | 0.00% | ||
2024-06-10 | Sale | CHIEF OPERATING OFFICER | 7,500 0.0128% | $81.85 | $613,845 | +16.15% | ||
2024-03-12 | Sale | CFO AND TREASURER | 6,480 0.0112% | $73.95 | $479,182 | +13.04% | ||
2024-03-07 | Sale | CHIEF COMMERCIAL OFFICER | 25,000 0.0434% | $75.68 | $1.89M | +10.65% | ||
2024-03-04 | Sale | director | 18,157 0.0312% | $76.03 | $1.38M | +8.81% | ||
2024-03-04 | Sale | director | 1,000 0.0017% | $76.35 | $76,348 | +8.81% | ||
2024-01-22 | Sale | director | 20,000 0.0342% | $80.00 | $1.6M | +1.23% | ||
2023-08-22 | Sale | CHIEF OPERATING OFFICER | 8,000 0.0137% | $67.91 | $543,288 | +8.31% | ||
2023-08-09 | Sale | director | 22,180 0.0386% | $69.40 | $1.54M | +6.14% | ||
2023-03-16 | Sale | CHIEF OPERATING OFFICER | 8,000 0.0135% | $68.75 | $550,000 | +5.71% | ||
2023-03-14 | Sale | PRESIDENT AND CEO | 24,977 0.0431% | $68.26 | $1.71M | +8.66% | ||
2023-03-14 | Sale | CHIEF HUMAN RESOURCES OFFICER | 2,000 0.0035% | $68.31 | $136,620 | +8.66% | ||
2023-03-08 | Sale | director | 11,585 0.0202% | $66.71 | $772,789 | +12.27% | ||
2023-03-06 | Sale | director | 15,000 0.0261% | $66.74 | $1M | +11.77% | ||
2023-03-03 | Sale | CFO AND TREASURER | 1,023 0.0018% | $70.00 | $71,610 | +6.61% | ||
2023-03-02 | Sale | PRESIDENT AND CEO | 19,176 0.0334% | $69.86 | $1.34M | +6.89% |
Parra Raul Jr. | CFO AND TREASURER | 16361 0.0281% | $104.70 | 1 | 13 | +56.98% |
LAMPROPOULOS FRED P | PRESIDENT AND CEO | 967916 1.6608% | $104.70 | 3 | 66 | +29.33% |
Frost Ronald | CHIEF OPERATING OFFICER | 15144 0.026% | $104.70 | 1 | 10 | <0.0001% |
Karras Nolan E. | director | 10500 0.018% | $104.70 | 3 | 9 | +20.13% |
PERRY RASHELLE | Chief Legal Officer | 9435 0.0162% | $104.70 | 2 | 12 | +21.69% |
BlackRock | $720.15M | 16.36 | 9.51M | -4.92% | -$37.23M | 0.02 | |
The Vanguard Group | $516.95M | 11.75 | 6.82M | -0.88% | -$4.57M | 0.01 | |
William Blair Investment Management | $230.5M | 5.24 | 3.04M | -19.73% | -$56.67M | 0.6 | |
State Street | $169.84M | 3.86 | 2.24M | +0.79% | +$1.33M | 0.01 | |
Arrowmark Colorado Holdings Llc | $165.53M | 3.76 | 2.19M | -0.31% | -$514,418.25 | 0.41 |